Page 97 - Outpatient Coder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Outpatient coder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Outpatient Coder Today - Breaking & Trending Today

BBCNEWS BBC News October 2, 2021 11:13:00

So obviously a lot easier to administer and a lot easier to administer as an outpatient as well. merck hopes 10 million courses of the treatment will be available by the end of the year. it has agreed to supply the us with close to 2 million, and to license the drug to several india based generic drug makers, which could supply it to low and middle income countries. for countries that don t have the vaccine available, this could be another stopgap. the us authorities say the drug is no substitute for preventative vaccines, but this is an exciting development as the us drug company seeks emergency approval within weeks as the first company to report trial results of an effective and relatively cheap pill to treat covid. as others companies also work on similar treatments. mark lobel, bbc news. the number of deaths caused ....

The End , 10 Million , Don T , Generic Drug Makers , 2 Million , Trial Results , Drug Company , Emergency Approval , Bbc News , Mark Lobel ,

BBCNEWS BBC News October 2, 2021 12:24:00

This drug will still work for that coronavirus. because it is agnostic to variants. there are existing clinic based intravenous treatments which are even more effective, but this appears to be the first pill to treat covid, and as long as it s taken early on could offer an alternative at roughly a third of the price at $700 per treatment. accessibility is a problem with a monoclonal antibody. for this one, it s a simple pill so obviously a lot easier to administer and a lot easier to administer as an outpatient as well. merck hopes 10 million courses of the treatment will be available by the end of the year. it has agreed to supply the us with close to 2 million, and to license the drug to several india based generic drug makers, which could supply it to low and middle income countries. for countries that don t have the vaccine available, this could be another stopgap. the us authorities say the drug is no substitute ....

Monoclonal Antibody , Per Treatment , The End , 10 Million , Don T , Generic Drug Makers , 2 Million ,

BBCNEWS BBC News October 2, 2021 03:03:00

The data still needs to be peer reviewed. so how does it work? as coronavirus replicates itself inside your body, these antiviral pills trick it into using the drug, which then inserts errors into the virus s genetic code, blocking the virus from replicating. there are existing intravenous treatments, but this is the first pill and, as long as it s taken early on, would offer an alternative at a third of a price at $700 a treatment. accessibility is a problem with monoclonal antibody. for this one, it s a simple pill, so obviously a lot easier to administer it and a lot easier to administer as an outpatient as well. merck says it s making 10 million courses of the treatment by the end of the year, with 1.7 million of those already paid for by the us government. game changer is probably a bit of a stretch, but absolutely helps push us forward. and that s kind of how we see it is this moving back to a normal society, ....

Genetic Code , Monoclonal Antibody , The End , 10 Million , Game Changer , 1 7 Million ,

BBCNEWS BBC News October 2, 2021 13:15:00

It could be still useful. people are now talking about this, that if we have another coronavirus pandemic in the future, this drug will still work for that coronavirus. because it is agnostic to variants. there are existing clinic based intravenous treatments which are even more effective, but this appears to be the first pill to treat covid, and as long as it s taken early on could offer an alternative at roughly a third of the price at $700 per treatment. accessibility is a problem with a monoclonal antibody. for this one, it s a simple pill so obviously a lot easier to administer and a lot easier to administer as an outpatient as well. merck hopes 10 million courses of the treatment will be available by the end of the year. it has agreed to supply the us with close to 2 million, and to license the drug to several india based generic drug makers, which could supply it to low and middle income countries. ....

Per Treatment , Monoclonal Antibody , 10 Million , The End , Generic Drug Makers , 2 Million ,

BBCNEWS BBC News October 2, 2021 09:18:00

Replicating- code, blocking the virus from re-ulicatin. , , ., replicating. it corrupts the genome ofthe replicating. it corrupts the genome of the virus replicating. it corrupts the genome of the virus so replicating. it corrupts the genome of the virus so it replicating. it corrupts the genome of the virus so it can t replicating. it corrupts the genome of the virus so it can t replicate, i of the virus so it can t replicate, and that of the virus so it can t replicate, and that is of the virus so it can t replicate, and that is the beauty. and then, even and that is the beauty. and then, even if and that is the beauty. and then, even if the and that is the beauty. and then, even if the virus mutates, it could be still even if the virus mutates, it could be still useful. people are now talking be still useful. people are now talking about this, that if we have another talking about this, that if we have another coronavirus pandemic in the future, another coronav ....

Genome Ofthe Replicating , Corona Virus , Virus Replicating , Re Ulicatin , Covid 19 , Per Treatment , Ht 700 Per Treatment , The End , Es 10 Outpatient , 10 Million , 2 Million ,